Riskified exits its May earnings print with short sellers adding exposure and company insiders heading for the exits — a combination that gives this week's modest price slide an extra edge.
The stock closed at $4.58 on Tuesday, down 5% on the week and 2.1% on the day, despite being up 14.5% over the past month. That month-long gain appears to have been the trigger for both the short build and the insider activity now playing out.
Short positioning has moved with unusual speed since late April. Short interest as a percentage of the free float climbed from 1.6% on April 23 to 2.4% by May 12 — a near-50% jump in under three weeks and the highest reading in the 30-day window tracked here. On a raw share count, shorts grew 11% over the past week alone, and are up 26% on the month. The borrow market is loose enough that this build can continue without friction: cost to borrow is running at 0.69% annually, up 39% on the week but still well below any level that would pressure short sellers. Availability is not a constraint. Options positioning reinforces the picture — the put/call ratio of 0.115 is roughly in line with its 20-day average of 0.118 and sits near the low end of the 52-week range, signalling that options traders remain call-heavy and not particularly hedged despite the short build.
The insider picture is the more arresting angle. In April and May, multiple founders and senior executives sold shares. The CEO sold 92,000 shares on April 6 across two transactions. The CTO sold a combined 61,000 shares across April and May. The CFO sold 67,643 shares. A divisional president added another 118,866 shares to the sell tally on the same day. Net insider activity over the trailing 90 days is technically positive at +340,090 shares, but the recent_trades list is entirely sells. The April 6 cluster coincided with the stock trading near $3.92–$3.96, before the 14.5% monthly run took it higher. The CTO's May 1 sale at $4.68 — the most recent transaction — came as the stock approached its near-term high, suggesting founders were trimming into strength.
The Street's view on Riskified is cautious at best. The consensus sits at hold, with two analysts carrying that rating and the mean price target at $5.55 — roughly 21% above the current price. But the most recent analyst data is dated: the freshest move came from Truist Securities in early March, when analyst Terry Tillman lowered his target from $8 to $7 while maintaining a Buy. Most of the analyst activity in the record clustered around the August 2025 earnings cycle, when the group broadly trimmed targets and JPMorgan briefly downgraded to Underweight before upgrading back to Neutral in November. The analyst dataset is stale enough — the as_of date is late March — that current Street sentiment should be treated with caution. On the fundamental side, the forward picture is modestly constructive: estimated revenue near $379 million, an EV/EBITDA around 6.6x on consensus estimates, and a net cash position of roughly $183 million that provides balance sheet cushion. The 12-month forward EPS estimate trajectory ranks in the 89th percentile by ORTEX factor scores — forward earnings expectations are rising, even if the stock has struggled to get credit for it.
The ORTEX short score of 34.6 is steady and not elevated, consistent with a building-but-not-extreme short position. Closest peers LiveRamp and Weave both fell on the week — RAMP down 4.7%, WEAV down 10.8% — so sector headwinds are real. Gen Digital bucked the move, gaining 11.8% on the week, suggesting the software tape is mixed rather than uniformly weak.
The next confirmed earnings date is August 12. Between now and then, the pattern to watch is whether the short build sustains against a stock that has already bounced 14.5% in a month, and whether insider selling continues now that the price is running back toward analyst target territory.
See the live data behind this article on ORTEX.
Open RSKD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
